Yujun Dong

1.0k total citations
124 papers, 598 citations indexed

About

Yujun Dong is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Yujun Dong has authored 124 papers receiving a total of 598 indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Hematology, 38 papers in Oncology and 38 papers in Immunology. Recurrent topics in Yujun Dong's work include Hematopoietic Stem Cell Transplantation (24 papers), Acute Myeloid Leukemia Research (20 papers) and Multiple Myeloma Research and Treatments (19 papers). Yujun Dong is often cited by papers focused on Hematopoietic Stem Cell Transplantation (24 papers), Acute Myeloid Leukemia Research (20 papers) and Multiple Myeloma Research and Treatments (19 papers). Yujun Dong collaborates with scholars based in China, United States and Canada. Yujun Dong's co-authors include Hanyun Ren, Zeyin Liang, Xinan Cen, Jicheng Lv, Ramy Ibrahim, Yue Yin, Jiahua Qian, Jay A. Berzofsky, Lin Nong and Samir N. Khleif and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Yujun Dong

113 papers receiving 590 citations

Peers

Yujun Dong
Banerjee United Kingdom
Vinodh Pillai United States
Donna Horncastle United Kingdom
Banerjee United Kingdom
Yujun Dong
Citations per year, relative to Yujun Dong Yujun Dong (= 1×) peers Banerjee

Countries citing papers authored by Yujun Dong

Since Specialization
Citations

This map shows the geographic impact of Yujun Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yujun Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yujun Dong more than expected).

Fields of papers citing papers by Yujun Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yujun Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yujun Dong. The network helps show where Yujun Dong may publish in the future.

Co-authorship network of co-authors of Yujun Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Yujun Dong. A scholar is included among the top collaborators of Yujun Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yujun Dong. Yujun Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Bo, Chenchen Qin, Huihui Liu, et al.. (2024). Blockade of CCR5 and CXCR3 attenuates murine acute graft-versus-host disease through modulating donor-derived T-cell distribution and function. International Immunology. 36(10). 541–552. 1 indexed citations
2.
Li, Chunrui, Dehui Zou, He Huang, et al.. (2024). Impact of CAR T-Cell Persistence on Clinical Outcomes in Relapsed/Refractory Multiple Myeloma: Insights from the Phase 2 Fumanba-1 Study. Blood. 144(Supplement 1). 4761–4761. 2 indexed citations
3.
Yang, Xiaodi, Qingyun Wang, Bo Tang, et al.. (2024). Comparative analysis of dynamic transcriptomes reveals specific COVID-19 features and pathogenesis of immunocompromised populations. mSystems. 9(6). e0138523–e0138523. 1 indexed citations
4.
Yang, Xiaodi, et al.. (2024). Genomic differences of patients with hematologic malignancies in different age groups. Communications Biology. 7(1). 1630–1630.
5.
Yin, Yue, Yuan Li, Zeyin Liang, et al.. (2023). Combination of ST2 With Organ-Specific Biomarker is More Sensitive and Specific for the Diagnosis of Acute Graft-vs-Host Disease. Transplantation Proceedings. 55(7). 1706–1714. 2 indexed citations
6.
Wang, Qingya, Ji Li, Hanyun Ren, et al.. (2023). Clinical characteristics and prognostic factors analysis of core binding factor acute myeloid leukemia in real world. Cancer Medicine. 12(24). 21592–21604. 3 indexed citations
7.
Wang, Qian, Zeyin Liang, Yue Yin, et al.. (2023). Tocilizumab, an IL6-receptor antibody, proved effective as adjuvant therapy for cytokine storm induced by severe infection in patients with hematologic malignancy. Annals of Hematology. 102(4). 961–966. 7 indexed citations
9.
Li, Jialiang, Suxia Luo, Tianbo Liu, et al.. (2023). 684P Phase I trial of SHR-A1811 in HER2-expressing advanced gastric cancer (GC) or gastroesophageal junction adenocarcinoma (GEJ) and colorectal cancer (CRC). Annals of Oncology. 34. S478–S478. 8 indexed citations
10.
Wang, Feng‐Rong, Shihua Zhao, Yajun Li, et al.. (2023). Autologous hematopoietic stem cell transplantation improves survival outcomes in peripheral T-cell lymphomas: a multicenter retrospective real-world study. Annals of Hematology. 102(11). 3185–3193.
11.
Yuan, Jing, Zeyin Liang, Yujun Dong, & Hanyun Ren. (2023). Autoimmune Hemolytic Anemia After Cord Blood Transplantation: A Retrospective Single-Center Experience. Journal of Inflammation Research. Volume 16. 1–6. 1 indexed citations
12.
Nong, Lin, Mingyue Wang, Lihong Wang, et al.. (2023). Retrospective cohort evaluation of non-HIV Castleman disease from a single academic center in Beijing, China. Annals of Hematology. 103(1). 153–162. 2 indexed citations
13.
Ren, Hanyun, Zeyin Liang, Wei Liu, et al.. (2022). Comparable Outcomes in Acquired Severe Aplastic Anemia Patients With Haploidentical Donor or Matched Related Donor Transplantation: A Retrospective Single-Center Experience. Frontiers in Medicine. 8. 807527–807527. 6 indexed citations
14.
Cao, Min, Huihui Liu, Yujun Dong, et al.. (2021). Mesenchymal stem cells alleviate idiopathic pneumonia syndrome by modulating T cell function through CCR2-CCL2 axis. Stem Cell Research & Therapy. 12(1). 378–378. 12 indexed citations
15.
Nong, Lin, Xue Wang, Rui Wang, et al.. (2020). Predominant Stroma-Rich Feature in Hyaline Vascular Variant of Castleman Disease Is Associated With Paraneoplastic Pemphigus. American Journal of Clinical Pathology. 154(3). 403–413. 9 indexed citations
16.
Huang, Haohai, et al.. (2019). Clinical effectiveness of quercetin supplementation in the management of weight loss: a pooled analysis of randomized controlled trials. SHILAP Revista de lepidopterología. 1 indexed citations
17.
Chen, Xiaoping, et al.. (2014). Detection of Wolbachia genes in a patient with non-Hodgkin's lymphoma. Clinical Microbiology and Infection. 21(2). 182.e1–182.e4. 8 indexed citations
18.
Dong, Yujun, Jia Na, Jicheng Lv, et al.. (2009). Clinical and laboratory characterization of a large cohort of patients with Castleman disease retrospectively collected from a single center. Leukemia & lymphoma. 50(8). 1308–1317. 21 indexed citations
19.
Ai, Limei, et al.. (2008). Enhancement of anti-lymphoma immuno-effects mediated by dendritic cells pulsed with heat-stressed and rituximab-coated CD20+ lymphoma cells. International Journal of Hematology. 87(5). 459–466. 1 indexed citations
20.
Zhang, Xuan, Hong Shu, Fuxun Zhang, Xinping Tian, & Yujun Dong. (2006). Cell-ELISA detection of antineuronal antibodies in central nervous system involvement in systemic lupus erythematosus. Annals of the Rheumatic Diseases. 66(4). 530–532. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026